Skip to main content

Richter-Helm Biotechnology

The biotechnological joint venture Richter-Helm belongs to the HELM AG since July 2007 respectively beginning of 2008. 

Our main focus today:

Biopharmaceutical Development and Manufacturing

  • Recombinant proteins
  • Plasmid DNA
  • Vaccines

Biopharmaceutical Contract Services

  • From strain development to API production
  • Full analytical services

Business Development

  • Marketing and Sales
  • Global in- and out-licensing of biopharmaceutical projects
  • Full development up to finished product